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Abstract
Background: In addition to its classical effects on opioid receptors, morphine can activate glia and stimulate the
production of pro-inflammatory immune molecules which in turn counteract the analgesic properties of morphine.
We hypothesized that decreased morphine analgesia in females may be the result of exaggerated microglial
activation in brain regions critical for analgesia.
Methods: Male and female rats were treated with morphine and/or minocycline and morphine analgesia was
examined using the hot plate. We also examined the expression of microglial and astrocyte markers in the
pain pathway.
Results: Males treated with minocycline, a microglial inhibitor, exhibited a significant increase in acute morphine
analgesia as previously shown; however, morphine analgesia was not affected by minocycline pretreatment in female
rats. Minocycline decreased the expression of glial activation markers in the male spinal cord and periaqueductal gray
as expected; however, these same molecules were upregulated in the female.
Conclusions: These data describe a significant difference between males and females in the behavioral effects
following co-administration of morphine and minocycline.
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Background
Sex differences in the brain have been studied for de-
cades and are important for understanding sex differ-
ences in physiology and behavior. At baseline, sex
differences in the brain can sometimes be small or insig-
nificant but are often revealed or exacerbated following
stress, injury, disease, or treatment with a drug. For ex-
ample, opioids such as morphine are more effective at
producing analgesia, or decreasing pain sensitivity, in
males than in females [1–3]. In addition, male rats de-
velop a greater tolerance to and dependency upon opiate
drugs [4]. Increased opioid tolerance in males is associ-
ated with a significant decrease in the activation of neu-
rons within the periaqueductal gray-rostral ventromedial
medullary circuit compared to females in response to
morphine [3], suggesting that sex differences in mor-
phine function specifically within the periaqueductal
gray (PAG) and its associated neural circuits have an im-
portant role in determining sex differences in morphine
analgesia and tolerance [5].
Microglia are the primary immune cells of the brain.
One of their functions is to detect and respond to infec-
tions, toxins, and physiological stressors within the central
nervous system. One way in which they do this is via pat-
tern recognition receptors (PRRs) located on their cell
membrane. PRRs identify specific pathogen-associated
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molecular patterns (PAMPs) or more general “alarmins”
(e.g., markers of cellular distress) that elicit the production
of various cytokines and chemokines to stimulate a pro-
inflammatory response and attract other immune cells to
the affected area. For example, Toll-like receptor (TLR) 4
is a PRR which recognizes lipopolysaccharide (LPS), a cell
wall component of the gram-negative bacteria. In addition
to this classical function of TLR4, it also has the ability to
respond, either directly or indirectly via endogenous alar-
mins/danger-associated molecular patterns (DAMPs), to a
number of other foreign but non-pathogenic substances,
including air pollution, alcohol, amphetamines, and opi-
oids [6–10]. Specifically, morphine can activate the TLR4
receptor via its adapter protein, MD2, in addition to its
ability to activate the classical opioid receptors (μ, δ, and κ
opioid receptors) within the central nervous system [11].
Thus, drugs that inhibit the activity of microglia, such as
minocycline, can enhance morphine’s analgesia and
decrease the risk of tolerance, dependence, and asso-
ciated reward [12–14]. Notably, this has only been
previously explored in males. Thus, the current
experiment sought to determine whether treatment
with a microglial inhibitor, minocycline, could simi-
larly enhance morphine analgesia in females, thereby po-
tentially eliminating a sex difference in the efficacy of
morphine.
Given the well-known sex difference in opioid anal-
gesia and the recently discovered role of microglia in this
aspect of opioid function, the purpose of this study was
twofold. First, in Experiment 1, we determined whether
inhibiting microglial activation using the tetracycline
antibiotic minocycline would eliminate or significantly
reduce the sex difference in morphine analgesia. Second,
in Experiment 2, we examined whether treatment of
males and females with a single acute dose of morphine
produced a similar neuroimmune response within brain
regions critical for opioid analgesia, including the
ventrolateral (vl) PAG and the spinal cord and whether
the expression of these immune molecules was similarly
impacted by minocycline treatment in both males and
females. Given that morphine analgesia is more effective
in males than in females, we predicted that females
would exhibit greater microglial activation to acute
morphine administration than males and that mino-
cycline would decrease this activation and thereby
enhance morphine analgesia significantly more in fe-
males than in males.
Contrary to our initial predictions, pretreatment with
minocycline exacerbated the sex difference observed in
morphine analgesia (Experiment 1) and caused a differ-
ential neuroimmune response in males and females
within the vlPAG and spinal cord (Experiment 2). Thus,
in Experiment 3, we validated the effectiveness of
the dose of minocycline used to inhibit the classic
inflammatory response caused by activated microglia in
these same brain regions critical for opioid analgesia.
Methods
Animals and drug
Sprague–Dawley rats from Harlan Laboratories, (In-
dianapolis, IN) were used for these experiments. They
were housed in AAALAC-approved polypropylene
cages on a 12:12-h light:dark cycle maintained at 22 °C
with ad libitum access to food and water. All experi-
ments were performed in accordance with the Institu-
tional Animal Care and Use Committee of Duke
University and the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. In Experi-
ment 1, 16 male and 16 female rats were randomly
assigned to one of two experimental groups: water +
morphine (n = 8/sex) or minocycline + morphine (n =
8/sex) in order to test morphine analgesia on the hot
plate. In Experiment 2, 20 male and 20 female rats
were randomly assigned to one of four experimental
groups: water + saline (n = 5/sex), water + morphine
(n = 5/sex), minocycline + saline (n = 5/sex), or mino-
cycline + morphine (n = 5/sex) for the analysis of glial
(microglial and astrocytic) activation markers using
real-time PCR.
Morphine sulfate was obtained courtesy of the Na-
tional Institute of Drug Abuse (NIDA) Drug Supply Pro-
gram and was dissolved in 0.9 % saline in the free-base
concentrations described below. Minocycline hydro-
chloride (Cat. No. M9511) was obtained from Sigma
Aldrich (St. Louis, MO) and dissolved in tap water for
gavage at the concentrations described below.
Experiment 1: determine the effect of minocycline on
acute morphine-induced analgesia in male and female
rats as measured on the hot plate
Time course of morphine analgesia on the hot plate
First, we examined the full-time course of morphine an-
algesia in males and females using the hot plate. Sixteen
male and 16 female Sprague–Dawley rats were habitu-
ated for 1 min each day over 2 days to a hot plate while
it was turned off. On the third day, the hot plate was set
to 52.5 °C, and latency to respond to the heat was re-
corded when a rat picked up or licked its paw. Twenty
minutes later, latency to respond to the hot plate was
recorded again, and the average of these two latencies
was calculated as the baseline. Following the baseline
measurements, the rats were treated with a subcutane-
ous dose of morphine at either 4 mg/kg (n = 8/sex) or
8 mg/kg (n = 8/sex), and latency to respond to the hot
plate was recorded 20, 40, 60, 90, and 120 min following
the morphine injection. Throughout the course of all
hot plate experiments, if the rat did not respond to the
heat within 60 s, they were removed from the hot plate
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to avoid tissue damage, and they received a maximal re-
sponse latency of 60 s.
The maximal percent effectiveness (%MPE) was de-
termined by subtracting the average baseline response
latency (baseline) from the response latency obtained
after morphine administration and taking that as a
percent of the maximal response latency (60-s cutoff )
minus the average baseline response latency. Thus,
for example, a maximum 60-s response latency would
be 100 % MPE.
Minocycline administration and %MPE analysis
After we determined the time course of %MPE of mor-
phine on the hot plate, we used a separate cohort of rats
to determine baseline latencies to respond to the hot
plate following minocycline administration. Sixteen male
and 16 female rats were habituated for 1 min each day
over 3 days to a hot plate while it was turned off. At
8 pm on Day 3, half of the males (n = 8) and half of the
females (n = 8) were gavaged with 50 mg/kg of minocy-
cline, and the other half (n = 8/sex) were gavaged with
an equal volume of tap water (1.25 ml/kg) as a control.
Gavage was used in these experiments to administer
minocycline because, despite the few seconds of stress
associated with the procedure, it is a safe and highly ef-
fective route of administration for this drug, particularly
versus intraperitoneal administration of minocycline
which causes severe abdominal pain (unreported obser-
vations). In addition, the doses (50 mg/kg followed by
25 mg/kg 12 h later) and route of administration of min-
ocycline were chosen for these experiments because they
have previously been shown to effectively decrease levels
of LPS-induced cytokine expression, particularly IL-1β
in the male brain (Williamson et al. [15]). Ten hours
after the first minocycline dose, the rats were placed on
a hot plate set to 52.5 °C, and their latency to respond to
the heat was recorded. Two baseline latencies were ob-
tained from the rats at this time, approximately 20 min
apart. The average of these two baseline latencies was
calculated as Baseline 1.
Immediately after Baseline 1 was measured, rats were
gavaged with the second dose of 25 mg/kg minocycline,
and the control rats were gavaged with an equal volume
of water (1.25 ml/kg). One hour after the second dose of
minocycline was administered, the rats were tested two
times, 20 min apart, for a second baseline latency to the
hot plate set to 52.5 °C to determine whether the base-
line latency to the heat changed after the immediate ad-
ministration of minocycline (prior to the administration
of morphine). The average of these two baseline laten-
cies was calculated as Baseline 2. We saw no significant
effect of treatment or sex on the baseline latency to
respond to the hot plate before the morning dose of
minocycline (data not shown).
Four hours after the second dose of minocycline was
administered, all rats were injected subcutaneously with
1.8 mg/kg of morphine in 1 ml/kg saline. Twenty mi-
nutes later, all rats were tested for the latency to respond
on the hot plate at 52.5 °C. Subsequent doses of 1.4, 2.4,
2.4, and 2 mg/kg of morphine were administered to the
same rats after each test on the hot plate, a treatment
regimen that results in quarter log serum doses of
1.8 mg/kg initially, then 3.2, 5.6, 8, and 10 mg/kg as
previously published [5]. Again, throughout the course
of the hot plate experiments, if the rat did not re-
spond within 60 s to the hot plate, they were
removed from the hot plate and received a maximal
response latency of 60 s.
The maximal percent effectiveness (%MPE) was deter-
mined as described above. The maximum latency to
respond to the hot plate was 60 s.
Statistical analysis of maximal percent effectiveness
The %MPE at each dose was analyzed using a within
subjects two-way ANOVA to analyze sex and minocy-
cline as factors across doses. Significant interactions
were followed up with Tukey’s post hoc tests (p < 0.05)
to analyze individual comparisons.
Experiment 2: determine the effects of morphine and
minocycline on pro-inflammatory gene expression and
microglial activation in the spinal cord and periaqueductal
gray of male and female rats
A second set of rats that did not undergo behavioral
analysis on the hot plate was used for this experiment.
Half of the rats in each sex (n = 10) were gavaged with
50 mg/kg of minocycline, and the other half (n = 10)
were gavaged with an equal volume of tap water
(1.25 ml/kg) as a control at 8 pm. The next day at 8 am,
the same rats were gavaged with 25 mg/kg of minocycline
or an equal volume of tap water (1.25 ml/kg). One hour
after the second gavage, half of the rats in each treatment
group (n = 5) were injected subcutaneously with either sa-
line (1 ml/kg) or morphine (4 mg/kg) and sacrificed
20 min later. Four milligrams per kilogram of morphine
was selected based on its striking sex difference in anal-
gesic efficacy on the hot plate in Experiment 1.
Experiment 3: determine the effects of minocycline on
expression of pro-inflammatory cytokine IL-1β following
lipopolysaccharide treatment
An additional cohort of 32 male and 32 female Sprague–
Dawley rats was used for this experiment. At 8 pm on
Day 1, half of the rats in each sex (n = 16/sex) were
gavaged with 50 mg/kg of minocycline, and the other
half (n = 16/sex) were gavaged with an equal volume of
tap water (1.25 ml/kg) as a control. Twelve hours later,
at 8 am on Day 2, the same rats were gavaged with a
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second dose of minocycline at 25 mg/kg or an equal vol-
ume of tap water (1.25 ml/kg). One hour following the
second gavage of minocycline or water, rats were given
an intraperitoneal injection of either 100 μg/kg LPS at
1 ml/kg (n = 8/pretreatment/sex) or an equal volume of
sterile saline (n = 8/pretreatment/sex). Four hours fol-
lowing either LPS or saline injection, the rats were eu-
thanized, and the vlPAG, spinal cord, and hippocampus
were collected for real-time PCR analysis of the classic
pro-inflammatory cytokine interleukin-1β (IL-1β).
Real-time PCR
The lumbar region of the spinal cord and micropunches of
the ventrolateral (vl) periaqueductal gray (Bregma −
7.0 mm to approximately −8.00, Experiments 2 and 3)
and the whole hippocampus (Bregma −2.00 mm to
approximately −7.00 mm, Experiment 3 only) were
collected from each animal for the analysis of gene
expression. mRNA was extracted from the microdissec-
tions using Isol-RNA Lysis Reagent (Cat. No. 2302700, 5
Prime, Gaithersburg, MD). Extracted RNA was subjected
to DNase treatment and cDNA synthesis using the
QuantiTect Reverse Transcription Kit and protocol from
QIAGEN (Cat. No. 205311). Relative gene expression was
measured using Bio-Rad Universal SYBR Green Supermix
(Cat. No. 172–5121) in 10-μl reactions on a CFX96
Touch™ real-time PCR machine. The primers for each
gene analyzed were ordered through Integrated DNA
Technologies and diluted to a final concentration of
0.65 μM for the real-time PCR reaction. The sequences of
the primers were as follows: GAPDH: forward: GTTT
GTGATGGGTGTGAACC; reverse: TCTTCTGAGTGG
CAGTGATG; GFAP: forward: AGGGACAATCTCACA
CAGG; reverse: GACTCAACCTTCCTCTCCA; CD11b:
forward: CTGGGAGATGTGAATGGAG; reverse: ACT
GATGCTGGCTACTGATG; Toll-like receptor (TLR) 4
forward: CAGAGGAAGAACAAGAAGC; reverse: CCA
GATGAACTGTAGCATTC; CX3CR1: forward: TTCCT
CTTCTGGACGCCTTA; reverse: TAAACGCCACTGT
CTCCG; CX3CL1: forward: TCCAGGGCTGTCCCCG
CAAA; reverse: ACAGGCAGGCAAGCAGGCAG; and
IL-1β: forward: GAAGTCAAGACCAAAGTGG; reverse:
TGAAGTCAACTATGTCCCG.
Real-time PCR analysis
For each sample’s reaction, the quantitative threshold
amplification cycle number (Cq) was determined, and
the 2−ΔΔCq method was used using GAPDH as the refer-
ence gene to calculate the relative gene expression.
Statistical analysis of gene expression
For each gene, a 2 × 2 × 2 ANOVA with sex, minocy-
cline, and morphine (Experiment 2) or LPS (Experiment
3) as variables was used to analyze the relative gene
expression and determine significant (p < 0.05) interac-
tions of sex, morphine, and/or minocycline/LPS and sig-
nificant main effects of minocycline and morphine/LPS.
Only significant interactions were followed up with
Tukey’s post hoc test (p < 0.05) to analyze individual
comparisons.
Estrous cycle analysis
For most experiments, vaginal swabs were taken from
females to determine estrous cycle at the time of behav-
ioral analysis or tissue collection, and based on our
analysis, cycle phase did not significantly explain vari-
ability within or sex differences observed between treat-
ment groups.
Results
Experiment 1: examine the effect of minocycline on
morphine-induced analgesia in male and female rats
Time course analysis of morphine analgesia in males
and females
We found a significant sex difference in morphine anal-
gesia such that both the 4 mg/kg and the 8 mg/kg doses
of morphine produced significantly greater analgesia on
the hot plate in males compared to females (repeated-mea-
sures ANOVA: main effect of sex: F1,15 = 21.22; p = 0.00040,
Fig. 1a, and F1,15 = 49.95; p < 0.001, Fig. 1b, respectively).
Given that morphine analgesia peaked 20 min post
subcutaneous morphine administration and that the sex
difference was present 20 min post morphine administra-
tion, we chose 20 min as our time point of analysis for our
subsequent experiments.
Baseline hot plate latencies
We found no significant main effect or interaction of sex
or minocycline treatment on the baseline latencies ob-
tained on the hot plate at any time point examined
(Baseline 1: sex - F1,31 = 1.63, p = 0.21; minocycline - F1,31 =
0.03, p = 0.86; sex ×minocycline - F1,31 = 0.71, p = 0.40;
Baseline 2: F1,31 = 1.18, p = 0.28; minocycline - F1,31 = 0.07,
p = 0.79; sex ×minocycline - F1,31 = 0.01, p = 0.92). Baseline
latencies to respond on the hotplate were as follows (mean
± SEM) [females +water: 12.5 ± 0.73 s, females +minocy-
cline: 11.5 ± 1.22 s, males + water: 10.5 ± 0.87 s, males +
minocycline: 11.15 ± 0.94 s] or after the morning dose of
minocycline [females + water: 13.81 ± 1.85, females +mino-
cycline: 13.58 ± 1.50 s, males + water: 12.36 ± 1.31 s,
males + minocycline: 11.8 ± 1.20 s]. These data indi-
cate that neither sex nor minocycline treatment
affected the baseline latency to respond on the hot
plate.
Morphine analgesia with or without minocycline
Figure 2a depicts the dose response curve obtained fol-
lowing incremental doses of morphine administration in
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males and females treated with or without minocycline.
Similar to previous reports, we found a significant main
effect of sex on the analgesic response to morphine such
that males experience greater analgesia on the hot plate
at lower doses of morphine (main effect of sex: F1,26 =
37.01; p < 0.001). Interestingly, we also found a signifi-
cant interaction of sex and minocycline treatment
across doses (sex × treatment: F1,26 = 4.56; p = 0.041).
Post hoc analysis revealed that minocycline signifi-
cantly shifted the dose response curve only in males
such that males treated with minocycline exhibited
significantly greater analgesia to morphine at lower
doses of morphine than males treated with water (p <
0.05). In contrast, post hoc comparisons revealed that
minocycline had no effect in females compared to
controls (p = 0.82). We also calculated the ED50, or
the dose at which morphine produced a mean percent
effectiveness of 50 % (MPE 50 %) for morphine on
the hot plate, for the each rat (Fig. 2b). As expected,
the statistical analysis was identical to the repeated
measures above and revealed a significant main effect
of sex (F1,26 = 37.01; p < 0.001) and a significant inter-
action of sex and minocycline treatment (F1,26 = 4.56;
p = 0.041) on the ED50.
Fig. 1 Mean percent effectiveness of acute morphine analgesia in male and female rats. Male and female rats were treated with either 4 mg/kg
or 8 mg/kg of morphine sulfate subcutaneously. Morphine analgesia was measured using a hot plate set at 52.5 °C. The latency to respond to
the heat with a rear paw shake or lick was recorded 20, 40, 60, 90, and 120 min post morphine administration. a Morphine produced significantly
greater analgesia in males than females at a dose of 4 mg/kg (repeated-measures ANOVA: asterisk represents main effect of sex: F1,15 = 21.22;
p = 0.00040). b Morphine produced significantly greater analgesia in males than females at a dose of 8 mg/kg (repeated-measures ANOVA:
asterisk represents main effect of sex: F1,15 = 49.95; p < 0.001)
Fig. 2 Effects of minocycline and dose responses to morphine on the hot plate. After habituation to the apparatus, n = 8 rats per sex were
gavaged with 50 mg/kg minocycline, and n = 8 rats per sex were gavaged with an equal volume of water (1.25 ml/kg). Their latencies to respond
to the painful stimulus of the hot plate were taken 10 h post gavage, and they were recorded twice 20 min apart and averaged as Baseline
1 (see “Methods” section for full details). Immediately following Baseline 1 measurements, rats were either gavaged with a second dose of
minocycline (25 mg/kg) or equal volume of water a second time (1.25 ml/kg). One hour after the second gavage, latencies to respond to the
stimulus on the hot plate were recorded twice and averaged to obtain Baseline 2 (a). The dose response curve following incremental doses of
morphine (mg/kg) administration is graphed for rats in all groups. ED50 is marked to represent the doses of morphine that elicit 50 % MPE (b).
The ED50 (mg/kg) doses of morphine for males and females treated with or without minocycline are graphed to show the values of morphine
required to obtain 50 % MPE. Asterisk represents significant interaction of sex and minocycline treatment (p < 0.05); number sign represents
main effect of sex (p < 0.001)
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Experiment 2: determine the effects of morphine and
minocycline on pro-inflammatory gene expression and
microglial activation in the spinal cord and periaqueductal
gray of male and female rats
Glial activation markers and immune molecules in the
spinal cord
First, we analyzed the lumbar enlargement of the spinal
cord (Fig. 3a) for microglial and astrocytic activation
markers that have previously been shown to be in-
creased in response to morphine treatment within the
brain (Schwarz et al. [16]; [17]). Given our interesting
behavioral results, we hypothesized that morphine treat-
ment might activate microglia in the spinal cord to a
greater extent in females than males and that minocy-
cline treatment would only be effective at reducing
microglial activation in males and not in females.
Analysis of CD11b, a marker of microglial activation,
revealed a significant interaction of sex and minocycline
treatment (F1,32 = 5.15, p = 0.03), such that minocycline
significantly inhibited CD11b expression in males (p < 0.05)
but significantly increased CD11b expression in females
(p < 0.05; Fig. 3b). Surprisingly, however, we found no
effect of morphine on CD11b expression in either sex.
We also analyzed the expression of TLR4, the innate im-
mune receptor expressed on the surface of microglia that
responds to morphine exposure [11], to determine
whether females have significantly more TLR4 expression
in the spinal cord than males. Statistical analysis did not
reveal any significant main effects or interactions of sex
or treatment on TLR4 expression in the spinal cord
(Fig. 3b). Next, we examined the classic proinflammatory
cytokine IL-1β; however, we did not find any significant
main effects or interactions of sex, minocycline, or mor-
phine in the spinal cord (Fig. 3b).
GFAP is an astrocytic marker that also increases ex-
pression in response to morphine administration in the
brain (Schwarz et al. [16]). We sought to test the alter-
nate hypothesis that morphine could activate astrocytes
in the spinal cord to a greater extent in females than in
males and thus inhibit morphine analgesia significantly
more in females than in males. In addition, because as-
trocytes are not a known target for minocycline, this
Fig. 3 Relative gene expression in the lumbar region of the spinal cord. a depicts a diagram of the lumbar enlargement that was taken for RNA
extraction, cDNA synthesis, and real-time PCR analysis. Males and females were treated with either water (n = 8 per sex) or minocycline (n = 8 per
sex; 50 and 25 mg/kg 12 h later) then treated with morphine (4 mg/kg) or saline s.c. Tissue was collected 20 min post morphine administration.
Data were analyzed using a 2 × 2 × 2 ANOVA with sex, morphine treatment, and minocycline treatment as variables. Main effects and interactions
are depicted as indicated below. Graphs represent the mean ± SEM. b depicts the analysis of microglial and inflammatory markers of the spinal
cord, specifically CD11b, TLR4, and IL-1β. Analysis of CD11b revealed a main effect of sex (#p < 0.05) and interaction between sex and minocycline
treatment (*p < 0.05). c Analysis of the astrocyte marker, GFAP, shows a significant interaction between sex and minocycline treatment (*p < 0.05)
and a main effect of sex (#p = 0.001). d depicts the analysis of the fractalkine receptor CX3CR1 and its ligand CX3CL1. CX3CR1 reveals a main effect
of sex (#p < 0.05)
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alternate hypothesis could also explain the lack of effect
of minocycline in females relative to males. Interestingly,
statistical analysis of GFAP in the spinal cord revealed a
significant interaction between sex and minocycline
treatment (F1,32 = 5.59, p = 0.024) such that minocycline
significantly inhibited a morphine-induced increase in
GFAP expression in the male spinal cord (p < 0.05), but
in contrast minocycline significantly increased GFAP ex-
pression in females (p < 0.05; Fig. 3c).
Next, we examined the expression of the fractalkine
receptor (CX3CR1), a chemokine receptor expressed by
microglia, and its ligand, CX3CL1, a chemokine pro-
duced by neurons that modulates microglial activation
via activation of CX3CR1. Based on previous reports
(Schwarz et al. [16]; [18]), we hypothesized that if mor-
phine activates neurons via its classical opioid receptor
pathways that neurons may, in turn, decrease CX3CL1
production, which might increase microglial activation;
and this mechanism may be significantly different be-
tween males and females and/or significantly inhibited
by minocycline treatment. Statistical analysis of the frac-
talkine receptor (CX3CR1) revealed a significant main
effect of sex (F1,32 = 3.97, p ≤ 0.05; Fig. 3d), as males had
significantly elevated levels of CX3CR1 in the spinal
cord relative to females. The expression of the chemo-
kine, CX3CL1, did not show any main effects or interac-
tions of sex or treatment (Fig. 3d).
Glial activation markers and immune molecules in the
ventrolateral periaqueductal gray
Next, we examined the expression of these same genes
in the ventrolateral periaqueductal gray (vlPAG, Fig. 4a)
with the same predictions in mind; that morphine treat-
ment might activate microglia in the vlPAG to a greater
extent in females than in males and that minocycline
treatment would only be effective at reducing microglial
activation in males and not in females.
We found no significant effect of sex or treatment on
CD11b expression in the vlPAG (Fig. 4b). However, stat-
istical analysis of TLR4 expression in the vlPAG revealed
a significant interaction of sex and morphine (F1,32 =
5.52, p = 0.02; Fig. 4b). Specifically, morphine increased
TLR4 expression in the vlPAG of males (p < 0.05) and
this effect was significantly inhibited by pretreatment
with minocycline (p < 0.05). In contrast, females had
significantly elevated levels of TLR4 relative to males
and these levels were not significantly influenced by
morphine treatment and/or minocycline administration.
Fig. 4 Relative gene expression in the ventrolateral periaqueductal gray (vlPAG). a represents a diagram of the ventrolateral periaqueductal gray
region that was taken for RNA extraction, cDNA synthesis, and real-time PCR analysis. Males and females were treated with either water (n= 8 per sex) or
minocycline (n= 8 per sex; 50 and 25 mg/kg 12 h later) then treated with morphine (4 mg/kg) or saline s.c. Tissue was collected 20 min post morphine
administration. Data were analyzed using a 2 × 2 × 2 ANOVA with sex, morphine treatment, and minocycline treatment as variables. Main effects and
interactions are depicted as indicated below. Graphs represent the mean ± SEM. b shows the graph of relative gene expression analysis using GFAP.
Number sign represents a main effect of sex (p< 0.05). c depicts the gene analysis for CD11b, TLR4, and IL-β in the vlPAG. TLR4 shows a main effect of sex
(#p< 0.05) and an interaction between sex and minocycline treatment (*p< 0.05). d represents the relative gene expression analysis of fractalkine receptor
CX3CR1 and its ligand CX3CL1. Both show a main effect of sex (#p< 0.05)
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Next, IL-1β expression showed a trending interaction of
sex and minocycline (F1,32 = 3.78, p = 0.061; Fig. 4b). Fol-
lowing these data, we ran separate 2 × 2 ANOVA tests
within the males and females and found a significant
main effect of minocycline treatment in only the males
(F1,32 = 6.28, p = 0.0234) such that males that were ad-
ministered minocycline had significantly lower expres-
sion of IL-1β compared to their water-treated controls.
There was a significant main effect of sex on GFAP
expression in the vlPAG (F1,32 = 4.31, p = 0.04, Fig. 4c),
such that females had significantly more GFAP expres-
sion in the vlPAG than males regardless of treatment.
No other effects or interactions were determined to be
statistically significant.
We also measured the relative gene expression for the
chemokine receptor (CX3CR1) and its ligand (CX3CL1)
in the vlPAG. In this region, the receptor (CX3CR1)
showed a significant main effect of sex (F1,32 = 4.78,
p = 0.03) and of minocycline (F1,32 = 5.54, p = 0.02).
The cytokine, CX3CL1 (fractalkine) also showed this
main effect of sex (F1,32 = 7.37, p = 0.01) but showed
no other significant results (Fig. 4d).
Experiment 3: determine the effects of minocycline on
expression of pro-inflammatory cytokine IL-1β following
lipopolysaccharide treatment
Given our unexpected findings from Experiments 1 and
2, we sought to confirm the dose and effectiveness of
minocycline as a drug used to inhibit inflammation as
caused by activated microglia in both males and females.
Thus, we treated males and females with or without the
same dose of minocycline used in the previous experi-
ments, followed by administration of LPS or saline.
Analysis of IL-1β in the lumbar enlargement of the
spinal cord revealed an interaction of sex and LPS such
that IL-1β expression was significantly more elevated in
males after LPS treatment compared to females (F1,61 =
7.487; p = 0.008, Fig. 5a). Analysis also revealed an inter-
action of minocycline and LPS such that minocycline
pretreatment inhibited the LPS-induced increase in IL-
1β expression in both males and females (F1,61 = 11.213,
p = 0.001, Fig. 5a), and there was no significant inter-
action of sex and minocycline treatment.
We found similar effects in the analysis of IL-1β in the
vlPAG such that there was an interaction of sex and LPS
with males having a greater increase in IL-1β after LPS
administration compared to females (F1,61 = 8.178, p =
0.006) and an interaction of minocycline and LPS such
that minocycline inhibited the LPS-induced increase in
IL-1β expression in both males and females (F1,61 =
4.632, p = 0.37, Fig. 5b), with no significant interaction of
sex and minocycline treatment.
Lastly, we analyzed the expression of IL-1β in the
hippocampus of these rats as the hippocampus is par-
ticularly sensitive to immune activation. Analysis re-
vealed a main effect of LPS treatment such that in both
males and females, LPS significantly increased the
expression of IL-1β (F1,61 = 18.427, p < 0.001, Fig. 5c).
Additionally, we found a trend towards an interaction
of minocycline and LPS such that minocycline pretreat-
ment inhibited the LPS-induced increase of IL-1β
expression (F1,61 = 3.372, p = 0.072, Fig. 5c).
Discussion
The current experiments were designed to test whether
minocycline could enhance morphine analgesia in both
Fig. 5 Relative gene expression of IL-1β mRNA in the spinal cord, ventrolateral periaqueductal gray, and hippocampus of male and female rats
treated with lipopolysaccharide (100 μg/kg). Male and female rats were treated with either minocycline (one 50 mg/kg dose and second 25 mg/
kg dose administered 12 h apart) or water and 1 h after that with either 100 μg/kg of lipopolysaccharide (LPS) or sterile saline (1 ml/kg) intraperitoneal
(n = 8/group). Four hours later, the spinal cord, ventrolateral periaqueductal gray (vlPAG), and hippocampus were dissected for analysis of IL-1β mRNA
expression. Graphs represent the mean ± SEM. Different asterisk combinations (e.g., * vs. ** vs. ***) represent significantly different groups. Thus, similar
asterisk combinations are not significantly different from each other. a LPS significantly increased the production of IL-1β in the spinal cord of both
males and females but to a greater extent in males than in females (sex × LPS interaction: F1,62 = 7.48; p = 0.008). Minocycline significantly attenuated
the increase in LPS in both males and females (minocycline × LPS interaction: F1,62 = 11.21; p = 0.001). We found no significant interaction of
minocycline and sex (p = 0.263). b We found similar effects of LPS and minocycline treatment on IL-1β expression in the vlPAG (sex × LPS
interaction: F1,62 = 8.17; p = 0.006; minocycline × LPS interaction: F1,62 = 4.63; p = 0.037). c LPS significantly and similarly increased IL-1β in the
hippocampus of both males and females (main effect of LPS: F1,62 = 18.47; p < 0.001; minocycline × LPS: F1,62 = 3.32; p = 0.072)
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males and females, thereby eliminating the well-known
sex difference in morphine analgesia [2, 19–24]. Previous
reports indicate that morphine can activate microglia
and astrocytes in the brain and spinal cord and that as-
sociated inflammation or TLR4 activation can inhibit or
counteract the analgesic properties of morphine [12, 25,
26]. These non-specific effects of morphine treatment
can be reversed using the microglial inhibitor, minocy-
cline [27, 28]; however, this effect had only been previ-
ously examined in males despite well-known differences
in immune function and morphine analgesia between
males and females. Thus, this study sought to determine
whether minocycline treatment could increase the effi-
cacy of morphine in both males and females and thereby
potentially eliminate or reduce the sex difference in the
efficacy of this important opiate drug. First, our results
confirmed the numerous reports of sex differences in
morphine analgesia. Second, our data revealed an even
more striking sex difference in the efficacy of the micro-
glial inhibitor, minocycline, in its ability to impact mor-
phine analgesia in males but not in females. Finally, a
preliminary investigation of microglial activation
markers and associated immune molecules in the spinal
cord and vlPAG uncovered additional sex differences in
the effect of minocycline on these immune molecules
that may reveal potential mechanisms contributing to
the sex difference in morphine analgesia and minocy-
cline efficacy.
As expected, males exhibited greater morphine-
induced analgesia on the hot plate relative to females,
data that corroborates an abundance of previous litera-
ture [1–3, 19–24] demonstrating this significant sex dif-
ference in morphine effectiveness. Previous research
indicates that glial inhibitors, such as minocycline, sig-
nificantly enhance morphine-induced analgesia in males
[27, 28], suggesting that in the absence of minocycline,
morphine activates microglia and inhibits its analgesic
properties even after acute morphine administration.
Thus, we examined the impact of morphine and mino-
cycline on morphine analgesia and the activation of
microglia and astrocytes 20 min after morphine adminis-
tration. We hypothesized that morphine would activate
microglia to a greater extent in females than in males
and thus counteract the analgesic properties of mor-
phine significantly more in females compared to
males. Minocycline treatment significantly increased
the analgesic efficacy of morphine in males as
previously reported, but surprisingly, minocycline did
not affect morphine-induced analgesia at all in female
rats. The dose response curves in Fig. 2a depict a sig-
nificant leftward shift in the curve for males that
were treated with minocycline, but this same shift is
not seen in the dose response curve of females
treated with minocycline.
These results did not support our initial hypothesis
and would suggest one of three things: either (1) the
males have significantly more morphine-induced micro-
glial activation than females within brain regions that
modulate morphine-induced analgesia and thus inhibit-
ing microglial activation with minocycline enhances
morphine-induced analgesia significantly more in males
than it does in females; or (2) this dose of minocycline
(one 50 mg/kg dose and second 25 mg/kg dose adminis-
tered 12 h apart) is not as effective at inhibiting
morphine-induced microglial activation in females as it
is in males, regardless of the relative levels of morphine-
induced microglial activation; or (3) while microglia may
influence morphine analgesia in males, this is not the
case in females, and in fact microglia have effect on
morphine analgesia in females. To further investigate
these potential mechanisms, the expression of the
microglial activation marker, CD11b, and other immune
molecules in the lumbar enlargement of the spinal cord
and the vlPAG were examined.
The expression pattern for a number of genes in both
the spinal cord and the vlPAG were consistent with be-
havioral findings, though a few were not. Surprisingly,
CD11b expression, though often used as a proxy of
microglial activation, was not increased following mor-
phine administration in either the spinal cord or the
vlPAG of either sex. Given the evidence, it appears that
CD11b is not an appropriate marker for microglial acti-
vation in this particular model of acute morphine ad-
ministration, and that microglia may in fact be “active”
within 20 min post morphine administration but that
CD11b is not simultaneously upregulated as a result.
Additionally, morphine had no effect on the expression
of the classic pro-inflammatory marker IL-1β in either
the spinal cord or vlPAG of males and females. In con-
trast, morphine did increase the expression of TLR4 in
the vlPAG and of GFAP in the spinal cord after only
20 min, though only in male rats. This sex difference in
the response to morphine for TLR4 and GFAP supports
the first of the three potential explanations proposed
above, that males may in fact have greater morphine-
induced activation of glia such that inhibition of glia
with minocycline produces an increase in morphine an-
algesia selectively in males. However, it is also worth
noting the significant sex difference in baseline TLR4 ex-
pression in the vlPAG where control females have sig-
nificantly more TLR4 than control males. This might
suggest that females are more sensitive to PAMPs com-
pared to males. Contrastingly, in our subsequent experi-
ment using minocycline and LPS administration, we see
that LPS induces IL-1β expression significantly more in
males compared to females. Thus, it is possible that glial
activation by either morphine or LPS administration
causes males to make more TLR4 in response, as seen
Posillico et al. Biology of Sex Differences  (2015) 6:33 Page 9 of 12
20 min following morphine administration. These data
support our third hypothesis that suggests microglia in-
fluence male morphine analgesia and do not influence
female morphine analgesia, especially given that we do
not see a similar increase in TLR4 expression in females
following morphine administration at this time.
We also hypothesized that the function of the fractalk-
ine receptor, CX3CR1, and its chemokine ligand, CX3CL1,
would impact morphine analgesia and may be subse-
quently affected by minocycline pre-treatment. Previous
literature supports an anti-nociceptive function of the
fractalkine receptor in that that binding the ligand
CX3CL1 produced by neurons to the microglial receptor
CX3CR1 inhibits microglial function [29, 30]. We pre-
dicted that if morphine activated neurons through its clas-
sic opioid receptor pathway, neurons would decrease the
production of the ligand and thus increase microglial acti-
vation and prevent anti-nociception [18]. While we do not
find any significant effects of morphine on the expression
of CX3CL1 in either the spinal cord or PAG of either sex,
we do see significant differential sex differences in the
expression of the receptor CX3CR1 in the spinal cord and
PAG. Furthermore, other bodies of literature describe a
pro-nociceptive function of fractalkine in the spinal
cord [31, 32]. Given these conflicting evidence and
findings, it is difficult to interpret the function of this
sex difference in the fractalkine receptor on morphine
analgesia at this time.
Although morphine did not increase CD11b in the
spinal cord or vlPAG of either sex, minocycline did alter
the expression of immune markers in both the spinal
cord and vlPAG of males and females, though not en-
tirely as predicted. In support of our initial hypothesis
and the behavioral data, minocycline treatment inhibited
CD11b expression in the male spinal cord. Additionally,
expression of IL-1β was significantly decreased as a re-
sult of minocycline but in only male rats. Minocycline
also significantly inhibited the morphine-induced upreg-
ulation of GFAP expression in the spinal cord of male
rats and the morphine-induced upregulation of TLR4 in
the vlPAG. The significant decrease in GFAP expression
in males was quite intriguing as we did not expect mino-
cycline to have such an effect on astrocytes. However,
other reports indicate that minocycline can inhibit the
activation of astrocytes in addition to microglia [33–35]
and given the significant interactions between microglia
and other cells in the brain, including astrocytes, it is
possible that by inhibiting microglial activation with
minocycline, we indirectly impact the function of astro-
cytes and the expression of GFAP.
In contrast, minocycline increased CD11b and GFAP
expression in the spinal cord of females, data that is con-
sistent with the behavioral findings presented here indi-
cating that minocycline does not enhance morphine-
induced analgesia in females. It is not clear why minocy-
cline would have such opposing effects on the physi-
ology of males and females; however, sex differences in
the physiological effects of minocycline are not unique
to the present study. For example, in a model of
ischemic stroke, minocycline (two 45 mg/kg doses ad-
ministered 12 h apart) successfully inhibited the stroke-
induced upregulation of poly (ADP-ribose) polymerase,
a DNA repair enzyme associated with cell death, in both
males and females, yet minocycline was only neuropro-
tective against this model in male mice [36]. Addition-
ally, our data indicate that minocycline increases the
expression of microglial and astrocyte activation markers
in the spinal cord and vlPAG of only female rats, which
suggests that this dose does have a physiological effect,
though not the same effect produced in males.
It is also possible that the acute pain produced by ex-
posure to the hot plate in these experiments initiates a
differential inflammatory or cellular immune response in
males and females such that treatment with minocycline
inhibits the pain-induced activation of microglia in
males, thereby enhancing analgesia independent of mor-
phine, while minocycline has no effect on pain-induced
activation of microglia in females, thereby having no ef-
fect on morphine analgesia as our third hypothesis
states. This working hypothesis is supported by a recent
report indicating that pain or nerve injury activates
microglia in males, while the same pain or nerve injury
in females activates and recruits T cells. In this study,
inhibiting microglia had no impact on the pain hyper-
sensitivity produced by nerve injury in females, but it
significantly decreased pain hypersensitivity to the same
injury in males [37]. However, additional studies have
used varying doses of minocycline and found successful
suppression of inflammatory pain [38] and neuroprotec-
tion following thromboembolitic stroke [39] in both
males and females. In addition, our data also indicate
that the current dose of minocycline inhibits the synthe-
sis of IL-1β stimulated by lipopolysaccharide exposure to
similar levels in both males and females (Fig. 5). In
conclusion, this literature and the data presented here
indicate that the sex difference observed in minocycline
efficacy may be the result of sex differences in the mech-
anism of action of minocycline subsequently interacting
with the mechanism of the disease (or in this case the
other drug, morphine) and is not a result of sex differ-
ences in the required dose for efficacy.
Also in support of this hypothesis, it is well known
that there are other factors that can influence the anal-
gesic properties of morphine in females. For example,
sex differences in mu opioid receptor number and sensi-
tivity contribute to the well-known sex difference in
opioid analgesia, tolerance, and dependence [3, 5, 40]. In
addition, hormonal fluctuations associated with the estrous
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cycle contribute to differential sensitivity of morphine in
females as these hormones mediate the expression
and function of opioid receptors in the female spinal
cord [41–46]. These hormones also inhibit anti-
nociception by morphine at the level of the vlPAG in
females but not males [47–51], and these circulating
hormones impact the function of neurons in hypo-
thalamic nuclei that directly interact with these down-
stream targets [47]. It is also possible that hormones
may similarly influence the glial or neuroimmune re-
sponses to morphine in female rats independent of mino-
cycline. In one study, TLR4 activation via LPS produced
allodynia in only male rats [52]. Researchers found that re-
moving male circulating testosterone significantly allevi-
ated LPS-induced allodynia, suggesting that testosterone
mediated the TLR4 signaling pathway in male rats while
this affect is not seen in female rats. Additionally, it has
been demonstrated that female sex steroids also influ-
ence the neuroimmune response to LPS. LPS-induced
pro-inflammation in male rats was significantly
attenuated in the presence of estradiol while pro-
inflammation in female rats was potentiated (Loram
et al. [53]). Though we found no impact of estrous
cycle phase on the behavioral or cellular response to
morphine in females in Experiments 1 and 2, our find-
ings do not discount the additional role that the estrous
cycle phase may have on any of the cellular effects of
morphine described above.
Conclusions
Most importantly, these data indicate that the effects of
drugs must be examined in both males and females. We
and others have repeatedly demonstrated that opioids
are more effective analgesics in males than in females.
Here, we also found that minocycline was significantly
more effective at inhibiting both microglia and astrocyte
activation in males than in females. In fact, in females,
this dose of minocycline appears to increase microglial
activation, though we see no decrease in morphine effect-
iveness in the hot plate following minocycline treatment.
These data exemplify the growing consensus in biomed-
ical research that sex must be considered as a factor when
examining the effectiveness, potential side effects, and in-
teractions of every medication. In this case, the combined
treatment of morphine and minocycline exaggerated the
baseline sex difference in the effectiveness of one drug
and resulted in significant differences in cell-type specific
function in the brain and spinal cord. Thus, our findings
extend the literature on sex differences in morphine anal-
gesia and elaborate on potential mechanisms for this sex
difference. These data highlight the importance of exam-
ining both sex and neural cell type when considering the
interactions, physiological effects, and behavioral effects of
specific therapeutic drugs alone or in combination.
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